Calumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) P/S ratio
As of 5 November 2026, Calumet, Inc. (CLMT) trades at a P/S ratio of 0.8×. Over the past ten years it has ranged from 0.0× (March 2020) to 1.1× (September 2026); the current reading is higher than 98% of that period. That is below the Specialty Chemicals industry median of 1.6× and below the Basic Materials sector median of 1.6×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.4× | (4.65%) |
| FY2024 | 0.4× | 30.02% |
| FY2023 | 0.3× | 21.42% |
| FY2022 | 0.3× | (16.43%) |
| FY2021 | 0.3× | 206.38% |
| FY2020 | 0.1× | 30.71% |
| FY2019 | 0.1× | 67.75% |
| FY2018 | 0.0× | (67.46%) |
| FY2017 | 0.2× | 70.80% |
| FY2016 | 0.1× | (76.62%) |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 0.7× | (8.19%) |
| Mar 2026 | 0.7× | 79.60% |
| Dec 2025 | 0.4× | 6.36% |
| Sep 2025 | 0.4× | 16.57% |
| 42 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| FUL H. B. Fuller Company compare | 0.8× |
| CLMT Calumet, Inc. | 0.8× |
| CBT Cabot Corporation compare | 1.0× |
| AVNT Avient Corporation compare | 1.2× |
| ASH Ashland Inc. compare | 1.9× |
| HWKN Hawkins, Inc. compare | 2.8× |
| SXT Sensient Technologies Corporation compare | 2.9× |
| WDFC WD-40 Company compare | 4.4× |
| PRM Perimeter Solutions, SA compare | 5.6× |
| Specialty Chemicals industry median | 1.6× |
| Basic Materials sector median | 1.6× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on CLMT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement